Literature DB >> 6107724

Biological and histological characteristics of simultaneous bilateral breast cancer.

D T Kiang, B J Kennedy, D C Snover.   

Abstract

Biological and histological characteristics of simultaneous bilateral breast cancers were studied in 11 patients: 8 had bilateral oestrogen receptor (ER)-positive tumours, 2 had bilateral ER-negative tumours; and only 1 case was asymmetric in receptor status. In contrast 5 of 7 asynchronous bilateral tumours demonstrated disparity in receptor status. The high incidence of bilateral positivity and similarity of receptor content in the simultaneous group suggests that the development of this group of tumours is probably hormonally related. Furthermore, the inverse relationship between tumour size and receptor content suggests an alteration in tumour characteristics during tumour progression.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6107724     DOI: 10.1016/s0140-6736(80)92541-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Bilateral breast cancer: one disease or two?

Authors:  P J Dawson; T Maloney; P Gimotty; P Juneau; H Ownby; S R Wolman
Journal:  Breast Cancer Res Treat       Date:  1991-11       Impact factor: 4.872

2.  The relationship between estrogen receptors in primary and secondary breast carcinomas and in sequential primary breast carcinomas.

Authors:  R Hähnel; E Twaddle
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

3.  Oestrogen receptor concentration in primary breast cancer and axillary node metastases.

Authors:  R A Hawkins; R Black; R J Steele; J M Dixon; A P Forrest
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

4.  Primary synchronous bilateral breast cancer: epidemiological approach.

Authors:  J Kelmendi de Ustarán; R P Meiss
Journal:  Breast Cancer Res Treat       Date:  1988-12       Impact factor: 4.872

5.  Second primary cancers of the breast: incidence and risk factors.

Authors:  T G Hislop; J M Elwood; A J Coldman; J J Spinelli; A J Worth; L G Ellison
Journal:  Br J Cancer       Date:  1984-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.